Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development.

Uncontrolled canonical Wnt signalling supports colon epithelial tumour expansion and malignant transformation. Understanding the regulatory mechanisms involved is crucial for elucidating the pathogenesis of and will provide new therapeutic targets for colon cancer. Epsins are ubiquitin-binding adaptor proteins upregulated in several human cancers; however, the involvement of epsins in colon ...
cancer is unknown. Here we show that loss of intestinal epithelial epsins protects against colon cancer by significantly reducing the stability of the crucial Wnt signalling effector, dishevelled (Dvl2), and impairing Wnt signalling. Consistently, epsins and Dvl2 are correspondingly upregulated in colon cancer. Mechanistically, epsin binds Dvl2 via its epsin N-terminal homology domain and ubiquitin-interacting motifs and prohibits Dvl2 polyubiquitination and degradation. Our findings reveal an unconventional role for epsins in stabilizing Dvl2 and potentiating Wnt signalling in colon cancer cells to ensure robust colon cancer progression. The pro-carcinogenic role of Epsins suggests that they are potential therapeutic targets to combat colon cancer.
Mesh Terms:
Adaptor Proteins, Signal Transducing, Adaptor Proteins, Vesicular Transport, Adenocarcinoma, Animals, Azoxymethane, Binding Sites, Colitis, Colon, Colonic Neoplasms, Gene Expression Regulation, Neoplastic, HT29 Cells, Humans, Mice, Mice, Knockout, Phosphoproteins, Primary Cell Culture, Protein Binding, Protein Interaction Domains and Motifs, Protein Stability, RNA, Small Interfering, Sodium Dodecyl Sulfate, Wnt Signaling Pathway, Xenograft Model Antitumor Assays
Nat Commun
Date: Apr. 15, 2015
Download Curated Data For This Publication
192010
Switch View:
  • Interactions 5